P. Brice

507 total citations
15 papers, 315 citations indexed

About

P. Brice is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, P. Brice has authored 15 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in P. Brice's work include Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Lung Cancer Treatments and Mutations (3 papers). P. Brice is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Lung Cancer Treatments and Mutations (3 papers). P. Brice collaborates with scholars based in France, Belgium and South Africa. P. Brice's co-authors include D M Dent, Peter Cheverton, I. D. Werner, Ben Novis, Josette Brière, Michel Blanc, Bruno César Corrêa Salles, Marine Diviné, Charles Dumontet and Jean‐Yves Blay and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

P. Brice

15 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Brice France 7 164 134 107 73 52 15 315
C Österreicher Austria 7 209 1.3× 115 0.9× 116 1.1× 45 0.6× 153 2.9× 9 321
P Westling Sweden 7 115 0.7× 107 0.8× 89 0.8× 55 0.8× 140 2.7× 10 323
Sudha Parasuraman United States 8 78 0.5× 102 0.8× 75 0.7× 37 0.5× 53 1.0× 15 304
Ahmet Sezer Türkiye 11 39 0.2× 235 1.8× 168 1.6× 33 0.5× 77 1.5× 48 402
Lilj Uziel Italy 7 247 1.5× 133 1.0× 34 0.3× 130 1.8× 18 0.3× 12 356
Annalisa Arcari Italy 11 159 1.0× 166 1.2× 12 0.1× 57 0.8× 23 0.4× 24 272
David L. Roseman United States 13 114 0.7× 246 1.8× 149 1.4× 52 0.7× 157 3.0× 22 505
L. Casanova Peru 7 132 0.8× 193 1.4× 48 0.4× 47 0.6× 28 0.5× 12 314
Ali Arıcan Türkiye 10 47 0.3× 128 1.0× 49 0.5× 11 0.2× 67 1.3× 37 226
Stewart Coltart United Kingdom 6 205 1.3× 147 1.1× 67 0.6× 88 1.2× 23 0.4× 7 281

Countries citing papers authored by P. Brice

Since Specialization
Citations

This map shows the geographic impact of P. Brice's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Brice with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Brice more than expected).

Fields of papers citing papers by P. Brice

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Brice. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Brice. The network helps show where P. Brice may publish in the future.

Co-authorship network of co-authors of P. Brice

This figure shows the co-authorship network connecting the top 25 collaborators of P. Brice. A scholar is included among the top collaborators of P. Brice based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Brice. P. Brice is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Huet, Sarah, Edith Szafer‐Glusman, Luc Xerri, et al.. (2017). EVALUATION OF CLINICOGENETIC RISK MODELS FOR OUTCOME OF FOLLICULAR LYMPHOMA PATIENTS IN THE PRIMA TRIAL. Hematological Oncology. 35(S2). 96–97. 6 indexed citations
2.
Bouteloup, Marie, John Seymour, Patrick Feugier, et al.. (2011). Pattern of infections observed during the maintenance phase in the PRIMA study. Ghent University Academic Bibliography (Ghent University). 1 indexed citations
4.
Delarue, Richard, Corinne Haïoun, P. Brice, et al.. (2004). CHOP and DHAP plus rituximab followed by autologous stem cell transplantation (ASCT) in mantle cell lymphoma (MCL): A pilot study from the GELA. Journal of Clinical Oncology. 22(14_suppl). 6529–6529. 2 indexed citations
5.
Viguier, M., H. Bachelez, P. Brice, Jacqueline Rivet, & Louis Dubertret. (2002). [Cutaneous B-cell lymphoma treatment with rituximab: two cases].. PubMed. 129(10 Pt 1). 1152–5. 14 indexed citations
6.
André, Marc, Nicolas Mounier, Xavier Leleu, et al.. (2001). Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma (NHL) with the ACVBP regimen. A GELA (Groupe d'Etude des Lymphomes de l'Adulte) cohort study on 2849 patients.. Blood. 98(11). 4 indexed citations
7.
Bosly, André, Anne Sonet, Gilles Salles, et al.. (1997). Late intensification is superior to early intensification in relapsing/refractory aggressive non-Hodgkin's lymphoma. A randomized study from the GELA: LNH RP93.. Experimental Hematology. 25(8). 16–16. 1 indexed citations
8.
Bosly, André, et al.. (1997). Superiority of late over early intensification in relapsing/refractory aggressive non-Hodgkin's lymphoma: A randomized study from the GELA: LNH RP 93. British Journal of Haematology. 102(1). 148–148. 7 indexed citations
9.
Bastion, Y, Jean‐Yves Blay, Marine Diviné, et al.. (1997). Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years.. Journal of Clinical Oncology. 15(8). 2945–2953. 162 indexed citations
10.
Bazarbachi, Ali, et al.. (1993). Changes in protein C, factor VII and endothelial markers after autologous bone marrow transplantation: possible implications in the pathogenesis of veno-occlusive disease.. PubMed. 35(2). 135–40. 13 indexed citations
11.
Cohen‐Haguenauer, Odile, et al.. (1993). [Gallium-67 scintigraphy in malignant lymphoma].. PubMed. 22(11). 521–5. 5 indexed citations
12.
Aractingi, S., et al.. (1992). [Methotrexate-induced skin detachment].. PubMed. 21(35). 1668–70. 11 indexed citations
13.
Trédaniel, Jean, Éric Lepage, J Frija, et al.. (1988). [Residual masses after chemotherapy of non-Hodgkin's lymphoma].. PubMed. 30(1-2). 75–7. 2 indexed citations
14.
Calvo, Felicitas Elena, et al.. (1986). [Treatment of infectious outbreaks in neutropenic patients with a piperacillin and amikacin combination].. PubMed. 15(46). 2353–7. 3 indexed citations
15.
Dent, D M, I. D. Werner, Ben Novis, Peter Cheverton, & P. Brice. (1979). Prospective randomized trial of combined oncological therapy for gastric carcinoma. Cancer. 44(2). 385–391. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026